Følg
Andrew Carr
Andrew Carr
St Vincent's Hospital and University of New South Wales, Sydney
Bekræftet mail på stvincents.com.au
Titel
Citeret af
Citeret af
År
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
A Carr, K Samaras, S Burton, M Law, J Freund, DJ Chisholm, DA Cooper
Aids 12 (7), F51-F58, 1998
29461998
Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial
ME Hannah, WJ Hannah, SA Hewson, ED Hodnett, S Saigal, AR Willan, ...
The Lancet 356 (9239), 1375-1383, 2000
24382000
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
20712003
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
A Carr, K Samaras, A Thorisdottir, GR Kaufmann, DJ Chisholm, ...
The Lancet 353 (9170), 2093-2099, 1999
18661999
Adverse effects of antiretroviral therapy
A Carr, DA Cooper
The Lancet 356 (9239), 1423-1430, 2000
14932000
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
14472006
Cardiovascular risk and body-fat abnormalities in HIV-infected adults
S Grinspoon, A Carr
New England Journal of Medicine 352 (1), 48-62, 2005
13492005
Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
A Carr, K Samaras, DJ Chisholm, DA Cooper
The Lancet 351 (9119), 1881-1883, 1998
13331998
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
10852008
A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome
A Carr, J Miller, M Law, DA Cooper
Aids 14 (3), F25-F32, 2000
7692000
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease
SA Danner, A Carr, JM Leonard, LM Lehman, F Gudiol, J Gonzales, ...
New England Journal of Medicine 333 (23), 1528-1534, 1995
6671995
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel
M Schambelan, CA Benson, A Carr, JS Currier, MP Dubé, JG Gerber, ...
J Acquir Immune Defic Syndr 31 (3), 257-75, 2002
5682002
An objective case definition of lipodystrophy in HIV-infected adults: a case-control study
A Carr, HIV Lipodystrophy Case Definition Study Group
The Lancet 361 (9359), 726-735, 2003
5662003
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
5572008
Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission
T Zhu, N Wang, A Carr, DS Nam, R Moor-Jankowski, DA Cooper, DD Ho
Journal of virology 70 (5), 3098-3107, 1996
5301996
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy
JS Currier, JD Lundgren, A Carr, D Klein, CA Sabin, PE Sax, JT Schouten, ...
Circulation 118 (2), e29-e35, 2008
4142008
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
A Carr, D Marriott, A Field, E Vasak, DA Cooper
The Lancet 351 (9098), 256-261, 1998
4061998
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
PWG Mallon, J Miller, DA Cooper, A Carr
Aids 17 (7), 971-979, 2003
4052003
Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III …
K Samaras, H Wand, M Law, S Emery, D Cooper, A Carr
Diabetes care 30 (1), 113-119, 2007
4022007
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
B Ledergerber, PLATO collaboration
The Lancet 364 (9428), 51-62, 2004
3882004
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20